204 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
19 Oct 23
Current report (foreign)
1:45pm
Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
4 Oct 23
RepliCel Provides Default Status Update and Announces Shareholder Approval of Equity Incentive Plan
2:23pm
.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
3zjyk3klcbvafefdmy9b
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.2
3fm6i0ta
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.1
8014h18lntqfn3i7
7 Sep 23
Current report (foreign)
12:26pm
6-K
EX-99.2
slep4pgzg2y xfdaqg
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
6-K
EX-99.1
77mle7wm
29 Aug 23
RepliCel announces the passing of long time Chief Financial Officer Simon Ma; David Kwok is appointed Chief Financial Officer
1:14pm
6-K
EX-99.2
2iw vfsah
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.4
y0pvcoodhxq
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.1
2poqy
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.1
9gyxhhuy
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
y0aawkm5ur e9mx6xg
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
6-K
EX-99.5
e59p2bq9 w4skck7
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
ley566cveb97
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
8e8ccnlh
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.2
8as 4jbb6blt8y
25 Oct 22
Current report (foreign)
12:27pm